Regional Node Dissection for Melanoma: Techniques and Indication

James W Jakub, Douglas S. Reintgen, Steven Shivers, Solange Pendas

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Because virtually all microscopic nodal disease left untreated in melanoma patients will progress to clinically apparent macroscopic nodal disease, there is worse prognosis with macroscopic nodal disease, and ineffective systemic treatment currently exists, one must be cautious in favoring an observation approach to the regional basin in patients with a positive sentinel lymph node (SLN) in the hopes of avoiding the potential morbidity of a therapeutic node dissection. In the few patients with untreated microscopic nodal disease, the prognosis will be significantly worsened. Until further data are available, melanoma patients with a positive SLN by H&E analysis should proceed to a complete lymph node dissection.

Original languageEnglish (US)
Pages (from-to)247-261
Number of pages15
JournalSurgical Oncology Clinics of North America
Volume16
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Dissection
Melanoma
Lymph Node Excision
Observation
Morbidity
Therapeutics
Sentinel Lymph Node

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Regional Node Dissection for Melanoma : Techniques and Indication. / Jakub, James W; Reintgen, Douglas S.; Shivers, Steven; Pendas, Solange.

In: Surgical Oncology Clinics of North America, Vol. 16, No. 1, 01.2007, p. 247-261.

Research output: Contribution to journalArticle

Jakub, James W ; Reintgen, Douglas S. ; Shivers, Steven ; Pendas, Solange. / Regional Node Dissection for Melanoma : Techniques and Indication. In: Surgical Oncology Clinics of North America. 2007 ; Vol. 16, No. 1. pp. 247-261.
@article{716cbe1717fa4ba78a6f18ee238ecc83,
title = "Regional Node Dissection for Melanoma: Techniques and Indication",
abstract = "Because virtually all microscopic nodal disease left untreated in melanoma patients will progress to clinically apparent macroscopic nodal disease, there is worse prognosis with macroscopic nodal disease, and ineffective systemic treatment currently exists, one must be cautious in favoring an observation approach to the regional basin in patients with a positive sentinel lymph node (SLN) in the hopes of avoiding the potential morbidity of a therapeutic node dissection. In the few patients with untreated microscopic nodal disease, the prognosis will be significantly worsened. Until further data are available, melanoma patients with a positive SLN by H&E analysis should proceed to a complete lymph node dissection.",
author = "Jakub, {James W} and Reintgen, {Douglas S.} and Steven Shivers and Solange Pendas",
year = "2007",
month = "1",
doi = "10.1016/j.soc.2006.10.012",
language = "English (US)",
volume = "16",
pages = "247--261",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Regional Node Dissection for Melanoma

T2 - Techniques and Indication

AU - Jakub, James W

AU - Reintgen, Douglas S.

AU - Shivers, Steven

AU - Pendas, Solange

PY - 2007/1

Y1 - 2007/1

N2 - Because virtually all microscopic nodal disease left untreated in melanoma patients will progress to clinically apparent macroscopic nodal disease, there is worse prognosis with macroscopic nodal disease, and ineffective systemic treatment currently exists, one must be cautious in favoring an observation approach to the regional basin in patients with a positive sentinel lymph node (SLN) in the hopes of avoiding the potential morbidity of a therapeutic node dissection. In the few patients with untreated microscopic nodal disease, the prognosis will be significantly worsened. Until further data are available, melanoma patients with a positive SLN by H&E analysis should proceed to a complete lymph node dissection.

AB - Because virtually all microscopic nodal disease left untreated in melanoma patients will progress to clinically apparent macroscopic nodal disease, there is worse prognosis with macroscopic nodal disease, and ineffective systemic treatment currently exists, one must be cautious in favoring an observation approach to the regional basin in patients with a positive sentinel lymph node (SLN) in the hopes of avoiding the potential morbidity of a therapeutic node dissection. In the few patients with untreated microscopic nodal disease, the prognosis will be significantly worsened. Until further data are available, melanoma patients with a positive SLN by H&E analysis should proceed to a complete lymph node dissection.

UR - http://www.scopus.com/inward/record.url?scp=33847312222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847312222&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2006.10.012

DO - 10.1016/j.soc.2006.10.012

M3 - Article

C2 - 17336247

AN - SCOPUS:33847312222

VL - 16

SP - 247

EP - 261

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 1

ER -